These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15537710)

  • 41. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
    Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J
    Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
    Allen PD; López JR; Sánchez V; Ryan JF; Sreter FA
    Anesthesiology; 1992 Jan; 76(1):132-8. PubMed ID: 1729917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine.
    Lopez JR; Allen P; Alamo L; Ryan JF; Jones DE; Sreter F
    Cell Calcium; 1987 Oct; 8(5):385-96. PubMed ID: 3427616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Halsall PJ; Steele DS
    Br J Anaesth; 2006 Sep; 97(3):320-8. PubMed ID: 16849381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
    Johannsen S; Treves S; Müller CR; Mögele S; Schneiderbanger D; Roewer N; Schuster F
    Neuromuscul Disord; 2016 Jan; 26(1):21-5. PubMed ID: 26631338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
    Foster PS; Denborough MA
    Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fiber-type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia.
    Adnet PJ; Bromberg NL; Haudecoeur G; Krivosic I; Adamantidis MM; Reyford H; Bello N; Krivosic Horber RM
    Anesthesiology; 1993 Jan; 78(1):168-77. PubMed ID: 8424551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study.
    Bina S; Capacchione J; Munkhuu B; Muldoon S; Bünger R
    Crit Care Med; 2015 Mar; 43(3):584-93. PubMed ID: 25479114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis.
    Lentz LR; Valberg SJ; Herold LV; Onan GW; Mickelson JR; Gallant EM
    Am J Vet Res; 2002 Dec; 63(12):1724-31. PubMed ID: 12492289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caffeine stimulation of malignant hyperthermia-susceptible sarcoplasmic reticulum Ca2+ release channel.
    Shomer NH; Mickelson JR; Louis CF
    Am J Physiol; 1994 Nov; 267(5 Pt 1):C1253-61. PubMed ID: 7977689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.
    Nelson TE
    J Clin Invest; 1983 Sep; 72(3):862-70. PubMed ID: 6886007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
    Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
    Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
    Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
    Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of human cultured myotubes responses mediated by ryanodine receptor 1.
    Kobayashi M; Mukaida K; Migita T; Hamada H; Kawamoto M; Yuge O
    Anaesth Intensive Care; 2011 Mar; 39(2):252-61. PubMed ID: 21485675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.